Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patients
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2021) - Comments
pubmed: 34801738  doi: 10.1016/j.ijid.2021.11.025  issn: 1201-9712  issn: 1878-3511 

Ravishankar Ramachandran, Vivek Bhosale, Himanshu Reddy, Virendra Atam, Mma Faridi, Jalees Fatima, Vaibhav Shukla, Zaw A Khan, Hana Khan, Vikram Singh, Mahendra Pal Singh Negi, Mukesh Srivastava, Ajay Kumar Srivastava, Chandra Bhushan Tripathi, Nayan Ghosh, Nilanjana Majumdar, Raj Kamal Tripathi, Srikanta Kumar Rath, Prabhat Ranjan Mishra, Sharad Sharma